In vitro studies on the inhibition of colon cancer by butyrate and carnitine.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nutrition (Burbank, Los Angeles County, Calif.)

• Publication date

  2009-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.nut.2009.04.008PMID 19619983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• l-Carnitine protects against apoptosis of murine MC3T3-E1 osteoblastic cells

  2008cited by this paper
• Kurozu moromimatsu inhibits tumor growth of Lovo cells in a mouse model in vivo

  2007cited by this paper
• Epithelial apoptosis in mechanistically distinct methods of injury in the murine small intestine.

  2007cited by this paper
• Kurozu moromimatsu inhibits tumor growth of Lovo cells in a mouse model in vivo.

  2007cited by this paper
• Histone deacetylase inhibitors: molecular mechanisms of action

  2007cited by this paper
• Review article: the role of butyrate on colonic function

  2007influential reference
• Does butyrate protect from colorectal cancer?

  2006cited by this paper
• Antioxidant and antiradical activities of L-carnitine.

  2006cited by this paper
• Anticancer activities of histone deacetylase inhibitors

  2006influential reference
• Foodstuffs and colorectal cancer risk: a review.

  2006cited by this paper
• High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish Mammography Cohort.

  2005cited by this paper
• pH and Peptide Supply Can Radically Alter Bacterial Populations and Short-Chain Fatty Acid Ratios within Microbial Communities from the Human Colon

  2005cited by this paper
• Clinical development of histone deacetylase inhibitors as anticancer agents.

  2005cited by this paper
• COX-2: a molecular target for colorectal cancer prevention.

  2005cited by this paper
• Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation.

  2005cited by this paper
• Cyclooxygenase-2 and its role in colorectal cancer development

  2004cited by this paper
• Chemoprevention of Cancer

  2004cited by this paper
• Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116

  2004cited by this paper
• Dietary regulation of intestinal gene expression.

  2003cited by this paper
• Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway

  2003cited by this paper
• Dairy products and colorectal cancer. A review of possible mechanisms and epidemiological evidence

  2003cited by this paper
• Delaying Brain Mitochondrial Decay and Aging with Mitochondrial Antioxidants and Metabolites

  2002cited by this paper
• The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.

  2002influential reference
• Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

  2002cited by this paper
• L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure.

  2002cited by this paper
• Cyclooxygenase-2: a novel target for cancer chemotherapy?

  2001cited by this paper
• Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression

  2000cited by this paper
• Expression of 5-lipoxygenase by human colorectal carcinoma Caco-2 cells during butyrate-induced cell differentiation.

  2000cited by this paper
• Effects of butyrate, conjugated linoleic acid and carnitine on Caco-2 cell proliferation and apoptosis

  2000cited by this paper
• Cancer and anticancer therapy‐induced modifications on metabolism mediated by carnitine system

  2000influential reference
• Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP)

  1999cited by this paper
• Tyrosine kinase and MAPK inhibition of TNF-alpha- and EGF-stimulated IEC-6 cell growth.

  1998cited by this paper
• Butyric acid from the diet: actions at the level of gene expression.

  1998influential reference
• Butyrate inhibits colon carcinoma cell growth through two distinct pathways.

  1998cited by this paper
• Tyrosine kinase and MAPK inhibition of TNF-α and EGF-stimulated IEC-6 cell growth

  1998cited by this paper
• Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer.

  1998cited by this paper
• Expression of 15-Lipoxygenase by Human Colorectal Carcinoma Caco-2 Cells during Apoptosis and Cell Differentiation*

  1998cited by this paper
• COMPARISON OF THE EFFECT OF DIFFERENT SHORT CHAIN FATTY ACIDS ON THE GROWTH AND DIFFERENTIATION OF HUMAN COLONIC CARCINOMA CELL LINESIN VITRO

  1997cited by this paper
• Fiber-derived butyrate and the prevention of colon cancer.

  1997cited by this paper
• Cows' milk fat components as potential anticarcinogenic agents.

  1997influential reference
• Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

  1997cited by this paper
• Butyrate and the colonocyte

  1996influential reference
• The war on cancer.

  1996cited by this paper
• Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease.

  1996cited by this paper
• Regulation of human colonic cell line proliferation and phenotype by sodium butyrate

  1996cited by this paper
• The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines.

  1995cited by this paper
• Butyrate and colonic cytokinetics: differences between in vitro and in vivo studies.

  1995cited by this paper
• Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines.

  1994cited by this paper
• Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.

  1994cited by this paper
• Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells.

  1993cited by this paper
• Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53‐independent pathway: Implications for the possible role of dietary fibre in the prevention of large‐bowel cancer

  1993cited by this paper
• Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation.

  1993cited by this paper
• Clinical pharmacology of sodium butyrate in patients with acute leukemia.

  1987cited by this paper
• Carnitine concentrations in the milk of different species and infant formulas.

  1987cited by this paper
• Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts.

  1986cited by this paper
• On Carnitine Content of the Human Breast Milk

  1982cited by this paper
• Suppression of histone deacetylation in vivo and in vitro by sodium butyrate.

  1978cited by this paper

• The mechanism of acetyl-L-carnitine on colorectal cancer and its metabolomic study.

  2026cites this paper
• Potential impact of L-threonine and encapsulated butyric acid (ButiPEARL) on growth performance, serum biomarkers, intestinal histomorphometry and economic indices of Nile tilapia fingerlings

  2025cites this paper
• Intestinal Butyrate Ameliorates Rheumatoid Arthritis Through Promoting the Expression of Cortistatin in Ileum via HDAC3—Vitamin D Receptor Pathway

  2025cites this paper
• Acidosis overrides molecular heterogeneity to shape therapeutically targetable metabolic phenotypes in colon cancers.

  2025cites this paper
• Promising roles of vitamin D receptor and APRO family proteins for the development of cancer stem cells targeted malignant tumor therapy

  2025cites this paper
• Review of the effects of sodium butyrate on obesity, inflammatory bowel disease, pregnancy and colorectal cancer

  2024cites this paper
• Prooxidant state in anticancer drugs and prospect use of mitochondrial cofactors and anti-inflammatory agents in cancer prevention

  2024cites this paper
• Novel metabolomic predictors of incident colorectal cancer in men and women.

  2024cites this paper
• Mechanic evaluation of Wu-Mei-Pill on colitis-associated colorectal cancer: An integrated transcriptomics, metabolomics, and experimental validation study.

  2024cites this paper
• The Potential Inhibitory Role of Acetyl-L-Carnitine on Proliferation, Migration, and Gene Expression in HepG2 and HT29 Human Adenocarcinoma Cell Lines

  2023cites this paper
• Exploring blood metabolites and thyroid disorders: a bidirectional mendelian randomization study

  2023cites this paper
• Investigation of L-carnitine effects on CD44+ cancer stem cells from MDA-MB-231 breast cancer cell line as anti-cancer therapy

  2023cites this paper
• Probiotics as multifaceted oral vaccines against colon cancer: A review

  2022cites this paper
• Sodium butyrate in both prevention and supportive treatment of colorectal cancer

  2022cites this paper
• Amelioration of 5-fluorouracil-induced intestinal mucositis by Streptococcus thermophilus ST4 in a mouse model

  2021cites this paper
• Cytotoxic effects of butyric acid derivatives through GPR109A receptor in Colorectal Carcinoma cells by in silico and in vitro methods

  2021cites this paper
• MEASURING THE CELLULAR RESPONSE OF MEAT-RELATED COMPONENTS ON HCT-COLON CANCER CELLS USING IN VITRO ASSAYS

  2021cites this paper
• The Nutraceutical Value of Carnitine and Its Use in Dietary Supplements

  2020cites this paper
• Effects of Short-Chain Fatty Acids on Human Oral Epithelial Cells and the Potential Impact on Periodontal Disease: A Systematic Review of In Vitro Studies

  2020cites this paper
• Microarray Analysis of Gene Expression Involved in Butyrate-Resistant Colorectal Carcinoma HCT116 Cells

  2020cites this paper
• Hafer bei Typ-2-Diabetes

  2018cites this paper
• Combination Regimens Using Dietary Components For The Chemoprevention Of Colorectal Cancer

  2018cites this paper
• Molecular Diversity of Gut Microbiota and Short Chain Fatty Acids in Egyptian Adults Following Dietary Intervention with Fermented Sobya

  2018cites this paper
• The effect of L-carnitine on colorectal cancer: A review on current evidence

  2018cites this paper
• In vitro activities of inulin fermentation products to HCT-116 cells enhanced by the cooperation between exogenous strains and adult faecal microbiota

  2018influential citation
• Celastrol Suppresses Tryptophan Catabolism in Human Colon Cancer Cells as Revealed by Metabolic Profiling and Targeted Metabolite Analysis.

  2018cites this paper
• Intestinal Microbiota Is Altered in Patients with Gastric Cancer from Shanxi Province, China

  2018cites this paper
• Hafer bei Typ-2-Diabetes: Eine Renaissance

  2018cites this paper
• Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array

  2017cites this paper
• In vitro cytotoxic activity of probiotic bacterial cell extracts against Caco-2 and HRT-18 colorectal cancer cells

  2016cites this paper
• Dietary Butyrate Helps to Restore the Intestinal Status of a Marine Teleost (Sparus aurata) Fed Extreme Diets Low in Fish Meal and Fish Oil

  2016cites this paper
• Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.

  2016cites this paper
• Acetylcarnitine potentiates the anticarcinogenic effects of butyrate on SW480 colon cancer cells.

  2015cites this paper
• Impacts of different cooking and storage methods on the retention and in vitro bioaccessibility of l-carnitine in veal muscle (M. longissimus dorsi)

  2015cites this paper
• Revisit dietary fiber on colorectal cancer: butyrate and its role on prevention and treatment

  2015cites this paper
• Diet-based strategies for cancer chemoprevention: the role of combination regimens using dietary bioactive components.

  2015cites this paper
• Human intestinal microbiota and metabolites they produce in relation to host health

  2014cites this paper
• Iron supplementation promotes gut microbiota metabolic activity but not colitis markers in human gut microbiota-associated rats

  2014cites this paper
• Effect of oral consumption of probiotic Lactobacillus planatarum P-8 on fecal microbiota, SIgA, SCFAs, and TBAs of adults of different ages.

  2014cites this paper
• Fecal metabolomics: assay performance and association with colorectal cancer.

  2014cites this paper
• Polyphenols, glucosinolates, dietary fibre and colon cancer: Understanding the potential of specific types of fruit and vegetables to reduce bowel cancer progression

  2014cites this paper
• Etude in vitro des propriétés probiotiques de bactéries du genre Bacillus : Interaction avec l’hôte et effets de l’association avec un prébiotique

  2014cites this paper
• Neurobehavioral effects of L-carnitine and its ability to modulate genotoxicity and oxidative stress biomarkers in mice.

  2013cites this paper
• Induction of Apoptosis by the Medium-Chain Length Fatty Acid Lauric Acid in Colon Cancer Cells due to Induction of Oxidative Stress

  2013cites this paper
• Effects of Butyrate on Colorectal Cancer

  2013cites this paper
• Evaluation of a novel, serum-based, biomarker screening test for colorectal cancer.

  2012cites this paper
• Development of low-calorie guava preserves with prebiotics and evaluation of their effects on carcinogenesis biomarkers in rats.

  2012cites this paper
• Carnitine sensitizes TRAIL-resistant cancer cells to TRAIL-induced apoptotic cell death through the up-regulation of Bax.

  2012cites this paper
• Global Foodomics strategy to investigate the health benefits of dietary constituents.

  2012cites this paper
• Butyrate Histone Deacetylase Inhibitors

  2012cites this paper
• The Effect of Selected Synbiotics on Microbial Composition and Short-Chain Fatty Acid Production in a Model System of the Human Colon

  2012cites this paper
• SATIETY, GLYCEMIC, AND GASTROINTESTINAL EFFECTS OF NOVEL FIBERS

  2012cites this paper
• Assessing the inhibition of azoxymethane-induced preneoplastic lesions in the rat colon by cooked resistant corn starches and identifying potential genetic targets

  2012cites this paper
• Use of Cellulose and Recent Research into Butyrate

  2012cites this paper
• Studies on the Chemopreventive Effect of Carnitine on Tumorigenesis In Vivo, Using Two Experimental Murine Models of Colon Cancer

  2012influential citation
• Zinc Sensing Receptor Signaling, Mediated by GPR39, Reduces Butyrate-Induced Cell Death in HT29 Colonocytes via Upregulation of Clusterin

  2012cites this paper
• Inhibition of azoxymethane-induced preneoplastic lesions in the rat colon by a cooked stearic acid complexed high-amylose cornstarch.

  2011cites this paper
• prevention of colorectal cancer? and colorectal cancer: a putative role for probiotics in The intestinal microbiota, gastrointestinal environment

  2011cites this paper
• Lipase-catalyzed synthesis and characterization of 1-butanoyl-2-palmitoyl phosphatidylcholine, a potential lipidic prodrug of butyric acid.

  2011cites this paper
• Metabolic activities and probiotic potential of bifidobacteria.

  2011cites this paper
• The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?

  2011cites this paper
• Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β‐oxidation pathway

  2011cites this paper
• Stool-fermented Plantago ovata husk induces apoptosis in colorectal cancer cells independently of molecular phenotype

  2011cites this paper
• Modeling disorders of fatty acid metabolism in the mouse.

  2011cites this paper
• l-Carnitine induces recovery of liver lipid metabolism in cancer cachexia

  2011cites this paper
• Fatty acids as potential adjunctive colorectal chemotherapeutic agents

  2011cites this paper
• In Vitro Fermentation of Sugar Beet Arabino-Oligosaccharides by Fecal Microbiota Obtained from Patients with Ulcerative Colitis To Selectively Stimulate the Growth of Bifidobacterium spp. and Lactobacillus spp

  2011cites this paper
• Impact of beta-glucan on the faecal microbiota of polypectomized patients: a pilot study.

  2011cites this paper
• Butyrate increases the formation of anti-angiogenic vascular endothelial growth factor variants in human lung microvascular endothelial cells

  2010cites this paper